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Demographic and Echocardiographic Predictors of
Anatomic Site and Outcomes of Interventions for
Cardiogenic Peripheral Emboli
Gregory J. Landry, Rakendu Shukla, Auddri Rahman, Amir
F. Azarbal, Timothy K. Liem, Erica L. Mitchell, Gregory L.
Moneta. OregonHealth& ScienceUniversity, Portland,Ore
Objectives: The association between demographic
and echocardiographic ﬁndings with the site of cardiogenic
peripheral embolization is not known. We sought to deter-
mine if cardiogenic emboli have a random distribution or if
there are factors that predict site of embolization, limb
salvage and mortality.
Methods: Upper (UE) and lower extremity (LE) emboli
were evaluatedover a6yearperiod.Demographic (age, gender,
smoking, medical comorbidities) and echocardiographic data
were analyzed to determine predictors of embolic site. All
patients underwent surgical revascularization. Limb salvage
and mortality were compared with Kaplan-Meier analysis.
Results: 160 patients (72 male, 88 female) with
presumed cardiogenic emboli were identiﬁed, 56 UE
(35 right, 21 left) and 104 LE (42 right, 44 left, 18
bilateral). Males had signiﬁcantly more LE emboli
than females (76% vs 56%) and females more UE
(44% vs 24%; P ¼ .01). No other demographic factors
were statistically different. UE patients were more
likely to have atrial ﬁbrillation on admission (50% vs
30%; P ¼ .04), while there was a trend towards LE
patients having a higher percentage of aortic or mitral
valvular disease (47% vs 31%; P ¼ .06). 30 day limb
salvage was higher for UE compared to LE (100% vs
88%; P ¼ .02) There was a trend toward higher 30
day mortality in the LE group (14% vs 5%; P ¼ .08).
One year mortality in both groups was approximately
25%.
Conclusions: UE emboli are more frequent in women
and patients with active atrial ﬁbrillation. LE emboli are
more frequent in men and patients with valvular disease,
and are associated with increased 30 day limb loss and
mortality. These ﬁndings suggest gender- and cardiac-
speciﬁc differences in ﬂow dynamics leading to preferential
sites of peripheral embolization.
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Efﬁcacy of Stent Placement Versus Balloon Angioplasty
in Small Vessel of Femoropopliteal Disease
Norihiko Kamioka, Yoshimitsu Soga, Hideaki Aihara,
Yusuke Tomoi, Yohei Kobayashi. Kokura Memorial
Hospital, Kitakyushu-city, JapanObjectives: The aim of this study was to evaluate the
efﬁcacy of stent placement vs balloon angioplasty (BA) in
less than 4.5 mm diameter femoropopliteal (FP) lesions.
Methods: This study was a multicenter retrospective
analysis. A total of 2742 consecutive patients (3471limbs)
with FP disease and 196 limbs below 4.5 mm diameter
femoropopliteal lesions were analyzed in current study;
122 (31.2%) were implanted the self-expanding nitinol
stent, 269 (68.8%) were balloon angioplasty alone.
Results: The mean follow-up term were 1.6 6 1.6
years. The mean reference vessel diameter was 3.8 6 0.4
mm and the mean lesion length was 55.0 6 33.8 mm.
There was no signiﬁcant difference in overall primary
patency between BA group (73.9%, 52.2% and 44.5% at
1, 3 and 5 years) and stent group (65.5%, 47.3% and
37.6% at 1, 3 and 5 years; P ¼ .27), nor was there a signif-
icant difference with assisted-primary patency, secondary
patency and MACE between in the two groups (P ¼ .22,
0.99 and 0.18, respectively). The independent predictors
of primary patency were female gender, diabetes mellitus,
history of cerebrovascular disease and lesion length.
Conclusions: Implantation of the self-expanding
nitinol stent does not improves the primary, assisted-
primary and secondary patency and decrease MACE for
the femoropopliteal lesions in small vessels compared
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Population Based Study of 20-year Trends in Lower
Extremity Revascularizations and Amputations Among
Persons With Peripheral Arterial Disease
Jeff Nienaber, Manju Kalra, Mateus P. Correa, Jennifer St.
Sauver, Carin Smith, Thomas Bower, Audra A. Duncan,
Gustavo S. Oderich, Peter Gloviczki. Mayo Clinic,
Rochester, Minn
JOURNAL OF VASCULAR SURGERY
68S Abstracts May Supplement 2013Objectives: To determine trends in the incidence of
amputation and mode of revascularization [endovascular
(ENDO) vs open surgical (OPEN) vs both (HYBRID)]
among persons with peripheral arterial disease (PAD) in
a deﬁned population.
Methods: A population based cohort study of resi-
dents of a single county was conducted from 1990 to
2009. Procedures were identiﬁed by ICD9/CPT codes.
Age and gender-adjusted Poisson regression analysis was
used to determine 5-year incidence trends.
Results: A total of 773 residents (mean age 68.6 yrs)
underwent 1906 limb revascularization procedures; 61%
for critical limb ischemia (CLI) and 32% for claudication
with a median of two procedures per limb. The cohort
was predominantly male (58.5%; P < .0001) and Caucasian
(96.5%). Initial ENDO procedures were more frequently
for claudication (54%) and OPEN for CLI (58%). Five-
year incidence rates showed signiﬁcant decreases in
OPEN and increases in ENDO and HYBRID revasculari-
zations over the 20-year period (P < .001; Fig). Total
revascularizations increased from 91 to 118 (P ¼ .0014)
and amputations decreased from 21 to 13/100,000
person-years (P ¼ .0123). Primary amputations decreased
from 13 to 5/100,000 person-years (P ¼ .0002).
Conclusions: In this population based study spanning
20 years, the incidence of amputations and OPEN revascu-
larizations decreased signiﬁcantly among PAD patients,
with concomitant increases in total, ENDO and HYBRID
revascularizations.Fig.Author Disclosures: T. Bower: Nothing to disclose;
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Two-year Follow-up In Diabetic Patients With
Occlusive Disease of the SFA Treated With e-PTFE
Endografts Compared to Non-diabetics
Rombout Kruse1, Floris B. Poelmann1, Michel Reijnen3,
Robert Lind1, Frans L. Moll2, Wilbert M. Fritschy1.
1Isala Clinics, Zwolle, The Netherlands; 2UniversityMedical Centre Utrecht, Utrecht, The Netherlands;
3Rijnstate Hospital, Arnhem, The Netherlands
Objectives: Diabetic patients form an important chal-
lenge in treating occlusive disease of the SFA. In this study
we have evaluated the results of 327 patients treated in two
hospitals in the Netherlands over a 10-year period. These
patients were treated with an e-PTFE nitinol self-expand-
ing endograft in the SFA/popliteal region for occlusive
disease. The aim of this study is to compare the results of
patients with diabetes (DM), with patients that didn’t
have diabetes (non-DM).
Methods: Male to female ratio was 73.7 vs 26.3%.
Mean age during surgery was 69.03 years. All patients
included had clinical symptoms of Intermittend Claudica-
tion or critical Limb Ischaemia (CLI). SFA lesions of both
groups of patients were scored according to the Trans
Atlantic Inter Society Consensus (TASC II). Follow up
was done after 3, 6, and 12 months, and every year there-
after. 36.7% of patients had DM (n ¼ 120). Our objective
was to asses primary and secondary 2-year patency in both
DM patients and in non-DM patients and compared the
two. Statistical analysis was done formng Kaplan Meier
survival curves to describe patency during follow-up.
The two groups were compared using Log Rank
(Mantel-Cox) analysis. Follow up included duplex ultra-
sonography and ankle brachial indices as well as pysical
examination.
Results: No statistical differences were found between
the two groups with respect to age and TASC classiﬁcation.
TASC II classiﬁcation in DM group was TASC A/B/C/
D: 25/39/25/31 and in the non-DM group: 51/54/
37/65, P value .436 (N.S.). 2-year primary and secondary
patency was 60,8 and 90% in the DM group (n ¼ 120),
and 65.2, and 82.6% in the non-DM group (n ¼ 207).
Log-rank (mantel Cox) analysis of the two Kaplan Meier
curves showed P values of .442 and .069 (both NS).
Conclusions: 2 year primary and secondary patency
rates of DM patients were equal to that of non-DM
patients. The 2-year secondary patency of 90% in the
DM group could only be achieved with a follow up
program and subsequent intervention when needed.
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Factors Affecting Outcome After Endovascular Repair
(EVPAR) of Popliteal Artery Aneurysms (PAAs)
Ying Huang, Peter Gloviczki, Audra A. Duncan, Gustavo
S. Oderich, Manju Kalra, Mark D. Fleming, Thomas C.
Bower. Division of Vascular and Endovascular Surgery,
Mayo Clinic, Rochester, Minn
Objectives: To analyze factors affecting outcome after
EVPAR.
Methods: Clinical data of consecutive PAA patients
treated with EVPAR (2000-2012) were reviewed. Primary
endpoints were major adverse events: mortality, throm-
bosis, amputation, complications, reinterventions.
